Identification of novel variations in SLC6A8 and GAMT genes causing cerebral creatine deficiency syndrome

Cerebral creatine deficiency syndromes (CCDSs) are a group of rare mendelian disorders mainly characterized by intellectual disability, movement anomaly, behavior disorder and seizures. SLC6A8, GAMT, and GATM are known genes responsible for CCDS. In this study, seven pediatric patients with developmental delay were recruited and submitted to a series of clinical evaluation, laboratory testing, and genetic analysis. The clinical manifestations and core biochemical indications of each child were basically consistent with the diagnosis of CCDS. Genetic diagnosis determined that all patients were positive for SLC6A8 or GAMT variation. A total of 12 variants were identified in this cohort, including six novel ones. The frequency of these variants, the Revel scores and the conservatism of the affected amino acids support their pathogenicity. Our findings expanded the mutation spectrum of CCDS disorders, and provided solid evidence for the counseling to affected families.

Automated summary

This study identified several genetic variants in pediatric patients with developmental delay, confirming their diagnosis of cerebral creatine deficiency syndromes (CCDS). The findings expanded the knowledge of mutation spectrum in CCDS disorders and provided evidence for genetic counseling to affected families.